School of Pharmacy
Former Student Amy Dixon Heads to Tokyo for Paralympics
Dixon will compete in the paratriathlon, which combines a 750-meter open water swim, a 20-kilomoter bicycle race finished with a five-kilometer road race, on Aug. 28 and 29
AACP Recognizes Work of Experiential Education Team During Pandemic
UConn School of Pharmacy's Experiential Education team received an Award for Excellence in Experiential Education 2020-2021
Pharmacy Students Learn Product Development in TIP – Summer 2021
The TIP program offers unique opportunity for students to engage in real-world, cutting edge research in the focused setting of a startup company, where they can appreciate both the business and the technology that drive innovation.
UConn Student Research in Pharmaceutical Sciences – Summer 2021
"Summer 2021’s pharmaceutical focused research projects highlight the diverse opportunities for undergrad research for students in the School of Pharmacy and across UConn."
UConn Magazine: Underachiever No More
No one who knew Jim LaFlamme back in the ’70s would have predicted what he’s doing now.
Quarterly Recap of Pharmacy Faculty Research Grants FY 2021 Q3
The UConn School of Pharmacy congratulates the following Department of Pharmaceutical Sciences faculty and their teams for their FY 2021 Q3 research grant awards totaling $2,116,479.00:
Summer Undergraduate Researcher Mariam Zedan ’24 (PHARM)
The need for new antibiotics is crucial as drug-resistant strains of bacteria proliferate
The FDA’s Weak Drug Manufacturing Oversight is a Potentially Deadly Problem
The loss of tens of millions of COVID-19 vaccine doses due to poor manufacturing oversight underscores the value of inspections
School of Pharmacy Earns Full 8 Year Continued ACPE Accreditation
The UConn School of Pharmacy is pleased to announce that its Doctor of Pharmacy Program (Pharm.D.) has received a full eight-year accreditation by the Accreditation Council for Pharmacy Education (ACPE) Board of Directors.
The FDA’s Big Gamble on a New Alzheimer’s Drug
No one knows yet if the new drug will demonstrate significant benefits for patients